Health and Healthcare
Durect Files To Raise Cash (DRRX)
Published:
Last Updated:
Durect Corporation (NASDAQ: DRRX) has just filed for a shelf registration to sell up to $75,000,000.00 worth of securities. This shelf will allow the company to sell any combination of common stock, preferred stock, debt securities, warrants, or units.
No underwriters were named in this shelf registration. The companysaid that proceeds are for general corporate purposes. These includeclinical trials, research and development activities, capitalexpenditures, facilities expansion and to meet working capital needs.
Durect is a pharmaceutical company developing therapies based onproprietary drug formulations and delivery platform technologies withseveral products under development that are both in-house and thirdparty companies. It also manufactures and sells osmotic pumps used inlaboratory research, and design, develop and manufacture a wide rangeof standard and custom biodegradable polymers for pharmaceutical andmedical device clients.
The company is authorized to issue up to 110,000,000 shares of commonstock, and as of October 31, there were 81,948,053 shares ofcommon stock issued and outstanding.
Shares closed down over 12% today at $3.78 and shares have recoveredroughly 4% to $3.94 in after-hours trading. The 52-week trading rangeis $3.08 to $6.96.
Jon C. Ogg
November 4, 2008
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.